319 related articles for article (PubMed ID: 25689618)
1. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
2. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.
Chung HW; Kong HY; Lim JB
World J Gastroenterol; 2015 Feb; 21(7):2080-8. PubMed ID: 25717241
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker.
Lim JB; Kim DK; Chung HW
Cancer Sci; 2014 Oct; 105(10):1327-33. PubMed ID: 25154912
[TBL] [Abstract][Full Text] [Related]
5. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma.
Woo IS; Hong SH; Byun JH; Kang JH; Jeon HM; Choi MG
Cancer Invest; 2008; 26(3):256-61. PubMed ID: 18317966
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
[TBL] [Abstract][Full Text] [Related]
7. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
8. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.
Wu Y; Jiang M; Qin Y; Lin F; Lai M
Clin Chim Acta; 2018 Jun; 481():20-24. PubMed ID: 29476736
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
Li Y; Sun H; Guan J; Ji T; Wang X
Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
[TBL] [Abstract][Full Text] [Related]
10. The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis.
Wang K; Jiang X; Ren Y; Ma Z; Cheng X; Li F; Xiao J; Yu Z; Jiao Z
BMC Gastroenterol; 2020 Apr; 20(1):100. PubMed ID: 32276616
[TBL] [Abstract][Full Text] [Related]
11. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
12. Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.
Macoska JA; Begley LA; Dunn RL; Siddiqui J; Wei JT; Sarma AV
Prostate; 2008 Mar; 68(4):442-52. PubMed ID: 18196514
[TBL] [Abstract][Full Text] [Related]
13. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients.
Li L; Yin X; Meng H; Hu J; Yu Z; Xu J
Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795
[TBL] [Abstract][Full Text] [Related]
14. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
[TBL] [Abstract][Full Text] [Related]
16. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.
Chung HW; Lim JB
J Transl Med; 2014 Apr; 12():102. PubMed ID: 24745825
[TBL] [Abstract][Full Text] [Related]
18. CXCL5 overexpression is associated with late stage gastric cancer.
Park JY; Park KH; Bang S; Kim MH; Lee JE; Gang J; Koh SS; Song SY
J Cancer Res Clin Oncol; 2007 Nov; 133(11):835-40. PubMed ID: 17479287
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence.
Jiang Y; Xu H; Jiang H; Ding S; Zheng T
Cancer Biomark; 2016 Mar; 16(4):523-8. PubMed ID: 27062567
[TBL] [Abstract][Full Text] [Related]
20. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.
Lai H; Jin Q; Lin Y; Mo X; Li B; He K; Chen J
Tumour Biol; 2014 Oct; 35(10):10547-54. PubMed ID: 25060181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
